Pivotal bioVenture Partners Investment Advisor as of June 30, 2023
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 11 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 55.9 | $170M | 782k | 216.85 | |
| Vaxcyte (PCVX) | 13.1 | $40M | 793k | 49.94 | |
| Oculis Holding Ordinary Shares (OCS) | 9.7 | $29M | 2.4M | 12.33 | |
| Inozyme Pharma (INZY) | 6.7 | $20M | 3.7M | 5.57 | |
| Rallybio Corp (RLYB) | 4.5 | $14M | 2.4M | 5.66 | |
| Arcutis Biotherapeutics (ARQT) | 3.5 | $11M | 1.1M | 9.53 | |
| Fusion Pharmaceuticals | 2.4 | $7.3M | 1.6M | 4.67 | |
| Vigil Neuroscience (VIGL) | 1.7 | $5.3M | 561k | 9.40 | |
| Exscientia Ads (EXAI) | 1.5 | $4.6M | 771k | 5.92 | |
| Bolt Biotherapeutics (BOLT) | 0.8 | $2.4M | 1.9M | 1.28 | |
| Aligos Therapeutics (ALGS) | 0.2 | $722k | 743k | 0.97 |
